Delayed recurrence of atrial fibrillation 2 years after catheter ablation is associated with metabolic syndrome

International Journal of Cardiology

Volumn 223, Issue , 2016, Pages 276-281

  Baek, Yong Soo ^a   Yang, Pil Sung ^a   Kim, Tae Hoon ^a   Uhm, Jae Sun ^a   Kim, Jong Youn ^a   Joung, Boyoung ^a   Lee, Moon Hyoung ^a   Pak, Hui Nam ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Atrial fibrillation; Catheter ablation; Overweight; Progression; Recurrence

Indexed keywords

C REACTIVE PROTEIN;

ABLATION CATHETER; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; ATRIAL FIBRILLATION; CARDIAC MAPPING SYSTEM; CATHETER ABLATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; OXYGEN SATURATION; PAROXYSMAL ATRIAL FIBRILLATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SLEEP DISORDERED BREATHING; AGED; COHORT ANALYSIS; MIDDLE AGED; OVERWEIGHT; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; POLYSOMNOGRAPHY; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84982097950     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.08.222     Document Type: Article

References (36)

1. [1] Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001), 2370–2375.
2. [2] Prystowsky, E.N., Benson, D.W. Jr., Fuster, V., Hart, R.G., Kay, G.N., Myerburg, R.J., et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation 93 (1996), 1262–1277.
3. [3] January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland, J.C. Jr., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 64 (2014), e1–76.
4. [4] Oral, H., Pappone, C., Chugh, A., Good, E., Bogun, F., Pelosi, F. Jr., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354 (2006), 934–941.
5. [5] Hwang, E.S., Pak, H.N., Park, S.W., Park, J.S., Joung, B., Choi, D., et al. Risks and benefits of an open irrigation tip catheter in intensive radiofrequency catheter ablation in patients with non-paroxysmal atrial fibrillation. Circ. J. 74 (2010), 644–649.
6. [6] Weerasooriya, R., Khairy, P., Litalien, J., Macle, L., Hocini, M., Sacher, F., et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?. J. Am. Coll. Cardiol. 57 (2011), 160–166.
7. [7] Hsieh, M.H., Tai, C.T., Tsai, C.F., Lin, W.S., Lin, Y.K., Tsao, H.M., et al. Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 14 (2003), 598–601.
8. [8] Mun, H.S., Joung, B., Shim, J., Hwang, H.J., Kim, J.Y., Lee, M.H., et al. Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study. Heart 98 (2012), 480–484.
9. [9] Hsieh, M.H., Tai, C.T., Lee, S.H., Lin, Y.K., Tsao, H.M., Chang, S.L., et al. The different mechanisms between late and very late recurrences of atrial fibrillation in patients undergoing a repeated catheter ablation. J. Cardiovasc. Electrophysiol. 17 (2006), 231–235.
10. [10] Pathak, R.K., Middeldorp, M.E., Lau, D.H., Mehta, A.B., Mahajan, R., Twomey, D., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J. Am. Coll. Cardiol. 64 (2014), 2222–2231.
11. [11] Chao, T.F., Ambrose, K., Tsao, H.M., Lin, Y.J., Chang, S.L., Lo, L.W., et al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm. 9 (2012), 1185–1191.
12. [12] Chang, S.L., Tuan, T.C., Tai, C.T., Lin, Y.J., Lo, L.W., Hu, Y.F., et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am. J. Cardiol. 103 (2009), 67–72.
13. [13] Mohanty, S., Mohanty, P., Santangeli, P., Di Biase, L., Natale, A., Reply: to PMID 22464257. J. Am. Coll. Cardiol. 61 (2013), 110–111.
14. [14] Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., Smith, S.C. Jr., Lenfant, C., American Heart, A., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004), 433–438.
15. [15] Parati, G., Lombardi, C., Hedner, J., Bonsignore, M.R., Grote, L., Tkacova, R., et al. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur. Respir. J. 41 (2013), 523–538.
16. [16] Pak, H.N., Oh, Y.S., Lim, H.E., Kim, Y.H., Hwang, C., Comparison of voltage map-guided left atrial anterior wall ablation versus left lateral mitral isthmus ablation in patients with persistent atrial fibrillation. Heart Rhythm. 8 (2011), 199–206.
17. [17] Tedrow, U.B., Conen, D., Ridker, P.M., Cook, N.R., Koplan, B.A., Manson, J.E., et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women's Health Study). J. Am. Coll. Cardiol. 55 (2010), 2319–2327.
18. [18] Wang, T.J., Parise, H., Levy, D., D'Agostino, R.B. Sr., Wolf, P.A., Vasan, R.S., et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292 (2004), 2471–2477.
19. [19] Tsang, T.S., Barnes, M.E., Miyasaka, Y., Cha, S.S., Bailey, K.R., Verzosa, G.C., et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur. Heart J. 29 (2008), 2227–2233.
20. [20] Cha, Y.M., Friedman, P.A., Asirvatham, S.J., Shen, W.K., Munger, T.M., Rea, R.F., et al. Catheter ablation for atrial fibrillation in patients with obesity. Circulation 117 (2008), 2583–2590.
21. [21] Tang, R.B., Dong, J.Z., Liu, X.P., Long, D.Y., Yu, R.H., Kalifa, J., et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ. J. 73 (2009), 438–443.
22. [22] Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005), 1448–1454.
23. [23] Munger, T.M., Dong, Y.X., Masaki, M., Oh, J.K., Mankad, S.V., Borlaug, B.A., et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J. Am. Coll. Cardiol. 60 (2012), 851–860.
24. [24] Korantzopoulos, P., Kolettis, T.M., Galaris, D., Goudevenos, J.A., The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int. J. Cardiol. 115 (2007), 135–143.
25. [25] Iwasaki, Y.K., Shi, Y., Benito, B., Gillis, M.A., Mizuno, K., Tardif, J.C., et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm. 9 (2012), 1409–1416 (e1).
26. [26] Kim, T.H., Park, J., Park, J.K., Uhm, J.S., Joung, B., Lee, M.H., et al. Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: an analysis of over 600-patients. Int. J. Cardiol. 176 (2014), 841–846.
27. [27] Abed, H.S., Nelson, A.J., Richardson, J.D., Worthley, S.G., Vincent, A., Wittert, G.A., et al. Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation. Am. Heart J. 169 (2015), 655–662 (e2).
28. [28] Heijman, J., Voigt, N., Nattel, S., Dobrev, D., Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ. Res. 114 (2014), 1483–1499.
29. [29] Harada, M., Tadevosyan, A., Qi, X., Xiao, J., Liu, T., Voigt, N., et al. Atrial fibrillation activates AMP-dependent protein kinase and its regulation of cellular calcium handling: potential role in metabolic adaptation and prevention of progression. J. Am. Coll. Cardiol. 66 (2015), 47–58.
30. [30] Fuster, V., Ryden, L.E., Cannom, D.S., Crijns, H.J., Curtis, A.B., Ellenbogen, K.A., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006), e257–e354.
31. [31] Erickson, J.R., Joiner, M.L., Guan, X., Kutschke, W., Yang, J., Oddis, C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133 (2008), 462–474.
32. [32] Markides, V., Schilling, R.J., Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment. Heart 89 (2003), 939–943.
33. [33] Sotomi, Y., Inoue, K., Ito, N., Kimura, R., Toyoshima, Y., Masuda, M., et al. Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace 15 (2013), 1581–1586.
34. [34] Sotomi, Y., Inoue, K., Ito, N., Kimura, R., Toyoshima, Y., Masuda, M., et al. Cause of very late recurrence of atrial fibrillation or flutter after catheter ablation for atrial fibrillation. Am. J. Cardiol. 111 (2013), 552–556.
35. [35] Pathak, R.K., Middeldorp, M.E., Meredith, M., Mehta, A.B., Mahajan, R., Wong, C.X., et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J. Am. Coll. Cardiol. 65 (2015), 2159–2169.
36. [36] Pathak, R.K., Elliott, A., Middeldorp, M.E., Meredith, M., Mehta, A.B., Mahajan, R., et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: the CARDIO-FIT study. J. Am. Coll. Cardiol. 66 (2015), 985–996.